Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families

European Heart Journal - Tập 29 Số 13 - Trang 1670-1680 - 2008
Elijah R. Behr1, Chrysoula Dalageorgou1, Michael Christiansen2, Petros Syrris3, Siân Hughes3, Maite Tome3, Edward Rowland3, Steve Jeffery1, William J. McKenna3
1Cardiac and Vascular Division, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK
2Statens Serum Institut, Copenhagen, Denmark
3The Heart Hospital, University College Hospital, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bowker, 2003, Sudden, unexpected cardiac or unexplained death in England: a national survey, QJM, 96, 269, 10.1093/qjmed/hcg038

Behr, 2007, Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death, Heart, 93, 601, 10.1136/hrt.2006.099598

Behr, 2003, Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome, Lancet, 362, 1457, 10.1016/S0140-6736(03)14692-2

Tan, 2005, Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives, Circulation, 112, 207, 10.1161/CIRCULATIONAHA.104.522581

Schwartz, 1993, Diagnostic criteria for the long QT syndrome. An update, Circulation, 88, 782, 10.1161/01.CIR.88.2.782

Dillenburg, 2002, Is exercise testing useful in identifying congenital long QT syndrome?, Am J Cardiol, 89, 233, 10.1016/S0002-9149(01)02210-X

Swan, 1999, Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects, J Am Coll Cardiol, 34, 823, 10.1016/S0735-1097(99)00255-7

Antzelevitch, 2005, Brugada Syndrome: report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association, Circulation, 111, 659, 10.1161/01.CIR.0000152479.54298.51

McKenna, 1994, Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, Br Heart J, 71, 215, 10.1136/hrt.71.3.215

Hamid, 2002, Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria, J Am Coll Cardiol, 40, 1445, 10.1016/S0735-1097(02)02307-0

Splawski, 1998, Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1, Genomics, 51, 86, 10.1006/geno.1998.5361

Wang, 1995, SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome, Cell, 80, 805, 10.1016/0092-8674(95)90359-3

Brugada, 2004, Sudden death associated with short-QT syndrome linked to mutations in HERG, Circulation, 109, 30, 10.1161/01.CIR.0000109482.92774.3A

Bellocq, 2004, Mutation in the KCNQ1 gene leading to the short QT-interval syndrome, Circulation, 109, 2394, 10.1161/01.CIR.0000130409.72142.FE

Mohler, 2003, Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death, Nature, 421, 634, 10.1038/nature01335

Plaster N, 2001, Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome, Cell, 105, 511, 10.1016/S0092-8674(01)00342-7

Priori, 2005, A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene, Circ Res, 96, 800, 10.1161/01.RES.0000162101.76263.8c

Vatta, 2006, Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome, Circulation, 114, 2104, 10.1161/CIRCULATIONAHA.106.635268

Lahat, 2001, A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel, Am J Hum Genet, 69, 1378, 10.1086/324565

Priori, 2001, Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia, Circulation, 103, 196, 10.1161/01.CIR.103.2.196

Tester, 2004, Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cases, Mayo Clin Proc, 79, 1380, 10.4065/79.11.1380

Norman, 2005, Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy, Circulation, 112, 636, 10.1161/CIRCULATIONAHA.104.532234

Gerull, 2004, Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy, Nat Genet, 36, 1162, 10.1038/ng1461

Wei, 1999, Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel, Circulation, 99, 3165, 10.1161/01.CIR.99.24.3165

Tester, 2005, Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing, Heart Rhythm, 2, 507, 10.1016/j.hrthm.2005.01.020

Splawski, 2000, Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2, Circulation, 102, 1178, 10.1161/01.CIR.102.10.1178

Murphy, 2005, Natural history and familial characteristics of isolated left ventricular non-compaction, Eur Heart J, 26, 187, 10.1093/eurheartj/ehi025

Mahon, 2005, Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease, Ann Intern Med, 143, 108, 10.7326/0003-4819-143-2-200507190-00009

Richardson, 1996, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies, Circulation, 93, 841, 10.1161/01.CIR.93.5.841

Priori, 1999, Low penetrance in the long QT syndrome: clinical impact, Circulation, 99, 529, 10.1161/01.CIR.99.4.529

Zareba, 2003, Implantable cardioverter defibrillator in high-risk long QT syndrome patients, J Cardiovasc Electrophysiol, 14, 337, 10.1046/j.1540-8167.2003.02545.x

Moss, 2000, Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome, Circulation, 101, 616, 10.1161/01.CIR.101.6.616

Corrado, 2003, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 108, 3084, 10.1161/01.CIR.0000103130.33451.D2

Tester, 2007, Postmortem long QT syndrome genetic testing for sudden unexplained death in the young, J Am Coll Cardiol, 49, 240, 10.1016/j.jacc.2006.10.010

Schwartz, 2007, Can a message from the dead save lives?, J Am Coll Cardiol, 49, 247, 10.1016/j.jacc.2006.10.009

Schwartz, 2001, Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias, Circulation, 103, 89, 10.1161/01.CIR.103.1.89

Chugh, 2004, Postmortem molecular screening in unexplained sudden death, J Am Coll Cardiol, 43, 1625, 10.1016/j.jacc.2003.11.052

Arnestad, 2007, Prevalence of long-QT syndrome gene variants in sudden infant death syndrome, Circulation, 115, 361, 10.1161/CIRCULATIONAHA.106.658021

Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147

Westenskow, 2004, Compound mutations: a common cause of severe long-QT syndrome, Circulation, 109, 1834, 10.1161/01.CIR.0000125524.34234.13